Understanding ADHD: A European Perspective
Attention-deficit/hyperactivity disorder (ADHD) is a prevalent childhood psychiatric disorder that can significantly impact the lives of children and their caregivers. A recent study, "Access to diagnosis, treatment, and supportive services among pharmacotherapy-treated children/adolescents with ADHD in Europe," provides valuable insights into the challenges faced by caregivers in obtaining diagnosis and treatment for ADHD in Europe.
Key Findings from the CAPPA Survey
The Caregiver Perspective on Pediatric ADHD (CAPPA) survey involved caregivers from ten European countries, focusing on their experiences with ADHD diagnosis, treatment, and support services. Here are some critical findings:
- Mean time from first doctor visit to formal diagnosis was 10.8 months, with significant variation across countries.
- 31% of caregivers reported significant difficulty in obtaining an ADHD diagnosis.
- 44% of children did not receive behavioral therapy (BT), despite its importance in ADHD management.
- 47% of caregivers felt that sufficient resources were available to support them.
- 67% of caregivers believed schools could do more to help with their child's ADHD.
Implications for Practitioners
The findings from the CAPPA survey underscore the need for improved access to diagnosis and supportive services. Practitioners can enhance outcomes for children with ADHD by:
- Advocating for quicker and more efficient diagnostic processes.
- Ensuring that behavioral therapy is integrated into treatment plans.
- Collaborating with schools to provide better support for children with ADHD.
- Providing caregivers with comprehensive resources and support networks.
Encouraging Further Research
While the CAPPA survey provides valuable insights, there is a need for ongoing research to address the gaps in ADHD care. Practitioners are encouraged to contribute to research efforts that explore innovative solutions for improving ADHD diagnosis and treatment.
To read the original research paper, please follow this link: Access to diagnosis, treatment, and supportive services among pharmacotherapy-treated children/adolescents with ADHD in Europe: data from the Caregiver Perspective on Pediatric ADHD survey.
